• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

口服十一酸睾酮和睾酮后睾酮的绝对生物利用度。

Absolute bioavailability of testosterone after oral administration of testosterone-undecanoate and testosterone.

作者信息

Täuber U, Schröder K, Düsterberg B, Matthes H

出版信息

Eur J Drug Metab Pharmacokinet. 1986 Apr-Jun;11(2):145-9. doi: 10.1007/BF03189840.

DOI:10.1007/BF03189840
PMID:3770015
Abstract

The plasma levels of testosterone (T) were measured after oral administration of 25 mg T and 40 mg testosterone-undecanoate (TU) in a group of young women by a specific radioimmunoassay. Plasma levels were compared to those after intravenous administration of 1.5 micrograms testosterone/kg to another group of young women for determination of absolute bioavailability. Due to the high metabolic clearance rate of 24.5 ml/min/kg absolute systemic availability of free testosterone was calculated to 3.56 +/- 2.45%. Oral administration of testosterone undecanoate leads only to an absolute testosterone bioavailability of 6.83 +/- 3.32%.

摘要

通过特定放射免疫分析法,对一组年轻女性口服25毫克睾酮(T)和40毫克十一酸睾酮(TU)后的血浆睾酮水平进行了测量。将这些血浆水平与另一组年轻女性静脉注射1.5微克睾酮/千克后的血浆水平进行比较,以确定绝对生物利用度。由于代谢清除率高达24.5毫升/分钟/千克,计算得出游离睾酮的绝对全身利用率为3.56±2.45%。口服十一酸睾酮的绝对睾酮生物利用度仅为6.83±3.32%。

相似文献

1
Absolute bioavailability of testosterone after oral administration of testosterone-undecanoate and testosterone.口服十一酸睾酮和睾酮后睾酮的绝对生物利用度。
Eur J Drug Metab Pharmacokinet. 1986 Apr-Jun;11(2):145-9. doi: 10.1007/BF03189840.
2
Pharmacokinetic study in women of three different doses of a new formulation of oral testosterone undecanoate, Andriol Testocaps.三种不同剂量的新型口服十一酸睾酮制剂(安特尔胶囊)在女性中的药代动力学研究。
Pharmacotherapy. 2003 Oct;23(10):1257-65. doi: 10.1592/phco.23.12.1257.32707.
3
Absolute bioavailability of testosterone after oral administration of testosterone-undecanoate and testosterone.
Eur J Drug Metab Pharmacokinet. 1987 Jul-Sep;12(3):225-6. doi: 10.1007/BF03189902.
4
Contribution of lymphatically transported testosterone undecanoate to the systemic exposure of testosterone after oral administration of two andriol formulations in conscious lymph duct-cannulated dogs.在清醒的淋巴管插管犬口服两种安雄制剂后,经淋巴转运的十一酸睾酮对睾酮全身暴露量的贡献。
J Pharmacol Exp Ther. 2003 Sep;306(3):925-33. doi: 10.1124/jpet.103.052522. Epub 2003 Jun 13.
5
Important effect of food on the bioavailability of oral testosterone undecanoate.食物对口服十一酸睾酮生物利用度的重要影响。
Pharmacotherapy. 2003 Mar;23(3):319-25. doi: 10.1592/phco.23.3.319.32104.
6
Production and characterization of testosterone undecanoate-loaded NLC for oral bioavailability enhancement.制备并表征用于提高口服生物利用度的十一酸睾酮载纳米脂质载体。
Drug Dev Ind Pharm. 2011 Jan;37(1):8-14. doi: 10.3109/03639045.2010.489559.
7
Oral testosterone undecanoate in the management of delayed puberty in boys: pharmacokinetics and effects on sexual maturation and growth.口服十一酸睾酮治疗男孩青春期延迟:药代动力学及其对性成熟和生长的影响
J Clin Endocrinol Metab. 1992 Jul;75(1):37-44. doi: 10.1210/jcem.75.1.1619029.
8
Clinical efficacy of testosterone undecanoate in male hypogonadism.十一酸睾酮治疗男性性腺功能减退的临床疗效
Clin Endocrinol (Oxf). 1981 Jun;14(6):625-9. doi: 10.1111/j.1365-2265.1981.tb02974.x.
9
Efficacy and safety of two different testosterone undecanoate formulations in hypogonadal men with metabolic syndrome.两种不同十一酸睾酮制剂治疗代谢综合征性腺功能减退男性患者的疗效和安全性。
J Endocrinol Invest. 2010 Dec;33(11):776-83. doi: 10.1007/BF03350341. Epub 2010 Mar 10.
10
Strawberry Decreases Intraluminal and Intestinal Wall Hydrolysis of Testosterone Undecanoate.草莓可降低十一酸睾酮在腔内和肠壁的水解。
Molecules. 2021 Jan 5;26(1):233. doi: 10.3390/molecules26010233.

引用本文的文献

1
"Enhancing Oral Drug Absorption: Overcoming Physiological and Pharmaceutical Barriers for Improved Bioavailability"."增强口服药物吸收:克服生理和药物障碍以提高生物利用度"。
AAPS PharmSciTech. 2024 Oct 1;25(7):228. doi: 10.1208/s12249-024-02940-5.
2
Anabolic-androgenic steroids: How do they work and what are the risks?合成代谢雄激素类固醇:它们是如何工作的,以及有哪些风险?
Front Endocrinol (Lausanne). 2022 Dec 19;13:1059473. doi: 10.3389/fendo.2022.1059473. eCollection 2022.
3
The Roles of Androgens in Humans: Biology, Metabolic Regulation and Health.

本文引用的文献

1
Which testosterone replacement therapy?哪种睾酮替代疗法?
Clin Endocrinol (Oxf). 1984 Aug;21(2):97-107. doi: 10.1111/j.1365-2265.1984.tb03448.x.
2
Comparative pharmacokinetics of testosterone enanthate and testosterone cyclohexanecarboxylate as assessed by serum and salivary testosterone levels in normal men.通过正常男性血清和唾液睾酮水平评估庚酸睾酮和环己烷羧酸睾酮的比较药代动力学。
Int J Androl. 1984 Jun;7(3):181-7. doi: 10.1111/j.1365-2605.1984.tb00775.x.
3
Saliva and serum testosterone following oral testosterone undecanoate administration in normal and hypogonadal men.
雄激素在人体中的作用:生物学、代谢调节与健康。
Int J Mol Sci. 2022 Oct 8;23(19):11952. doi: 10.3390/ijms231911952.
4
Triglyceride-Mimetic Prodrugs of Buprenorphine Enhance Oral Bioavailability via Promotion of Lymphatic Transport.丁丙诺啡的甘油三酯模拟前药通过促进淋巴转运提高口服生物利用度。
Front Pharmacol. 2022 Apr 12;13:879660. doi: 10.3389/fphar.2022.879660. eCollection 2022.
5
Acceptability of the oral hormonal male contraceptive prototype, 11β-methyl-19-nortestosterone dodecylcarbonate (11β-MNTDC), in a 28-day placebo-controlled trial.11β-甲基-19-去甲睾酮十二烷酸酯(11β-MNTDC)口服男性避孕药原型的可接受性:28 天安慰剂对照试验。
Contraception. 2021 Nov;104(5):531-537. doi: 10.1016/j.contraception.2021.06.009. Epub 2021 Jun 18.
6
Strawberry Decreases Intraluminal and Intestinal Wall Hydrolysis of Testosterone Undecanoate.草莓可降低十一酸睾酮在腔内和肠壁的水解。
Molecules. 2021 Jan 5;26(1):233. doi: 10.3390/molecules26010233.
7
Lipids and Lipid-Processing Pathways in Drug Delivery and Therapeutics.脂质与脂质处理途径在药物传递和治疗学中的应用
Int J Mol Sci. 2020 May 4;21(9):3248. doi: 10.3390/ijms21093248.
8
Acceptability of oral dimethandrolone undecanoate in a 28-day placebo-controlled trial of a hormonal male contraceptive prototype.口服二甲双胍十一酸酯在 28 天安慰剂对照试验中作为男性激素避孕原型的可接受性。
Contraception. 2020 Jul;102(1):52-57. doi: 10.1016/j.contraception.2020.04.006. Epub 2020 Apr 13.
9
Prospects and Challenges of Phospholipid-Based Prodrugs.基于磷脂的前药的前景与挑战。
Pharmaceutics. 2018 Nov 1;10(4):210. doi: 10.3390/pharmaceutics10040210.
10
Quantitative characterization of UDP-glucuronosyltransferase 2B17 in human liver and intestine and its role in testosterone first-pass metabolism.定量描述人肝和肠中的 UDP-葡糖醛酸基转移酶 2B17 及其在睾酮首过代谢中的作用。
Biochem Pharmacol. 2018 Oct;156:32-42. doi: 10.1016/j.bcp.2018.08.003. Epub 2018 Aug 4.
正常男性和性腺功能减退男性口服十一酸睾酮后的唾液和血清睾酮水平
Acta Endocrinol (Copenh). 1983 Mar;102(3):456-62. doi: 10.1530/acta.0.1020456.
4
Mean plasma concentration, metabolic clearance and basal plasma production rates of testosterone in normal young men and women using a constant infusion procedure: effect of time of day and plasma concentration on the metabolic clearance rate of testosterone.
J Clin Endocrinol Metab. 1967 May;27(5):686-94. doi: 10.1210/jcem-27-5-686.
5
Androstenedione production and interconversion rates measured in peripheral blood and studies on the possible site of its conversion to testosterone.在外周血中测定的雄烯二酮生成和相互转化率以及关于其转化为睾酮的可能部位的研究。
J Clin Invest. 1966 Mar;45(3):301-13. doi: 10.1172/JCI105344.
6
[Testosterone metabolism in man. Peripheral testosterone metabolism].[男性体内的睾酮代谢。外周睾酮代谢]
Dtsch Med Wochenschr. 1967 Nov 10;92(45):2080-6. doi: 10.1055/s-0028-1106095.
7
The pharmacology and metabolism of testosterone undecanoate (TU), a new orally active androgen.十一酸睾酮(TU),一种新型口服活性雄激素的药理学与代谢
Acta Endocrinol (Copenh). 1975 Aug;79(4):789-800. doi: 10.1530/acta.0.0790789.
8
Plasma androgen levels in men after oral administration of testosterone or testosterone undecanoate.口服睾酮或十一酸睾酮后男性的血浆雄激素水平。
Acta Endocrinol (Copenh). 1975 Jun;79(2):366-74. doi: 10.1530/acta.0.0790366.
9
Oral testosterone, a reappraisal.口服睾酮:重新评估
Horm Res. 1978;9(3):121-9. doi: 10.1159/000178904.
10
Bioavailability of oral testosterone in males.男性口服睾酮的生物利用度。
Eur J Clin Pharmacol. 1979 Nov;16(5):345-9. doi: 10.1007/BF00605634.